Yield10 Bioscience Inc (YTEN)

[ash111]

10Q, the balance sheet remains solid, total assets/ total liabilities remains at a ratio of 5. net lose reduced by 20%. that's pretty good earnings. because the company expanded it's portfolio which usually brings more expenses but not in this case. a good job.

$YTEN 10Q, "Company's present capital resources will be sufficient to fund its planned operations and meet its obligations into the third quarter of 2019", an improvement of previous quarter (Mid- 2019).